celebrex joint swelling

Biologics

MiMedx releases AmnioFix Injectable

MiMedx Group Inc. announced the launch of its newest tissue product, AmnioFix Injectable, at the American Academy of Orthopaedic Surgeons 2012 Annual Meeting in San Francisco.

 According to a company press release, AmnioFix Injectable is an allograft composed of micronized amniotic tissue, which is processed to optimize surgical performance and ease of use. The company’s proprietary Purion process retains the amniotic growth factors and cytokines inherent in and unique to placental tissue, resulting in an injectable tissue that offers a natural ability to reduce inflammation at the injection site and enhance soft tissue healing. AmnioFix has a 5-year shelf-life.
Josh Sandberg has been recruiting specifically in the musculoskeletal industry since 2004. Throughout this time, he has been able to have a positive impact on his client’s businesses. With an educational background in Business Management, Josh is adept to discern which people will be the best fit for the company he is searching for by understanding how candidates will incorporate with the company’s culture and operational nuances. His experience as an executive in a start-up business has granted him the ability to understand what is takes to thrive in a hands–on environment, where desire and dedication are paramount for success.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>